[1]杨洋,苏文凌.亚临床甲状腺功能亢进与心血管疾病关系的研究进展[J].国际内分泌代谢杂志,2021,41(06):649-652.[doi:10.3760/cma.j.cn121383-20200827-08044]
　Yang Yang,Su Wenling..Research progress of the relationship between subclinical hyperthyroidism and cardiovascular disease[J].International Journal of Endocrinology and Metabolism,2021,41(06):649-652.[doi:10.3760/cma.j.cn121383-20200827-08044]
点击复制

亚临床甲状腺功能亢进与心血管疾病关系的研究进展()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
41
期数:
2021年06期
页码:
649-652
栏目:
综述
出版日期:
2021-12-20

文章信息/Info

Title:
Research progress of the relationship between subclinical hyperthyroidism and cardiovascular disease
作者:
杨洋; 苏文凌
天津市胸科医院内分泌科 300222
Author(s):
Yang Yang;  Su Wenling.
Department of Endocrinology, the Tianjin Chest Hospital, Tianjin 300222, China
关键词:
亚临床甲状腺功能亢进;  心脏;  血管
Keywords:
Subclinical hyperthyroidism;  Heart;  Blood vessels
DOI:
10.3760/cma.j.cn121383-20200827-08044
摘要:
亚临床甲状腺功能亢进(亚临床甲亢)是指促甲状腺激素(TSH)低于正常范围,而T3和T4正常的一种状态。亚临床甲亢的发病率并不低,尤其在老年人中。亚临床甲亢不管是否发展成甲亢,都会对机体造成一定的影响,所以受到越来越多学者的关注。在亚临床甲亢状态下,机体的血流动力学发生改变,导致心率增快,心输出量增加; 相对过剩的甲状腺激素通过基因组和非基因组的途径直接作用于心肌细胞,增加心肌收缩力,增加心排出量。在临床中,亚临床甲亢与房颤、心力衰竭、高血压、脑卒中等密切相关。随着年龄的增加,其对心血管系统的危害越来越大。因此,亚临床甲亢是值得关注的一种甲状腺功能紊乱状态。
Abstract:
Subclinical hyperthyroidism, defined by reduced TSH levels in the presence of normal free thyroxine and free triodothyronine values. The incidence rate of subclinical hyperthyroidism is not low, especially in old men; whether the subclinical hyperthyoidism develops into hyperthyoidism or not, it can damage the body and hence has obtained interests by more and more scholars. During subclinical hyperthyroidism, haemodynamics of the body has changed with increased heart rate and increased cardiac output. More thyroid hormones act directly on cardiac myocyte leading to increased cardiac contractility and heart output. The subclinical hyperthyroidism is related with atrial fibril lation, hypertension, heart failure, and stroke in clinical. The effects of subclinical hyperthyoidism on cardiovascular system is increasing with age. Subclinical hyperthyroidism is a state of dysthyroid which should to be paid.

参考文献/References:

[1] Goichot B,Caron P,Landron F,et al.Clinical presentation of hyperthyriodism in a large representative sample of outpatients in France:relationships with age,aetiologyand hormonal paramenters[J].Clin Endocrinal(Oxf),2016,84(3):445-451.DOI:10.1111/cen.12816.
[2] Delitala AP.Subclinical hyperthyroidism and the cardiovascular disease[J].Horm Metab Res,2017,49(10):723-731.DOI:10.1055/s-0043-117893.
[3] Biondi B,Cooper DS.Subclinical hyperthyroidism[J].N Engl J Med,2018,378(25):2411-2419.DOI:10.1056/NEJMcp1709318.
[4] 单忠艳,滕卫平.我国甲状腺疾病的防治现状、对策及挑战[J].诊断学理论与实践,2020,19(4):329-333.DOI:10.16150/j.1671-2870.2020.04.001.
[5] Floriani C,Gencer B,Collet TH,et al.Subclinical thyroid dysfunction and cardiovascular diseases:2016 update[J].Eur Heart J,2018,39(7):503-507.DOI:10.1093/eurheartj/ehx050.
[6] Biondi B,Cooper DS.Subclinical hyperthyroidism[J].N Engl J Med,2018,379(15):1484-1485.DOI:10.1056/NEJMc1809627.
[7] Hoermann R,Midgley JEM,Larisch R,et al.Heterogenous biochemical expression of hormone activity in subclinical/overt hyperthyroidism and exogenous thyrotoxicosis[J].J Clin Transl Endocrinol,2020,19:100219.DOI:10.1016/j.jcte.2020.100219.
[8] Zhang J,Huang C,Meng Z,et al.Gender-specific differences on the association of hypertension with subclinical thyroid dysfunction[J].Int J Endocrinol,2019,2019:6053068.DOI:10.1155/2019/6053068.
[9] Mastroianno S,Di Stolfo G,Maggio A,et al.Role of subclinical iatrogenic hyperthyroidism in the setting of heart disease and arrhythmic burden[J].Endocr Metab Immune Disord Drug Targets,2020,20(6):959-962.DOI:10.2174/1871530320666191227103627.
[10] 郑辉,常宝成,葛焕琦.3'-碘甲状腺原氨酸:保护心脏和调节代谢的新武器[J].国际内分泌代谢杂志,2019,39(2):124-127.10.3760/cma.j.issn.1673-4157.2019.02.013.
[11] Reyes Domingo F,Avey MT,Doull M.Screening for thyroid dysfunction and treatment of screen-detected thyroid dysfunction in asymptomatic,community-dwelling adults:a systematic review[J].Syst Rev,2019,8(1):260.DOI:10.1186/s13643-019-1181-7.
[12] Zoltek M,Andersson TM,Hedman C,et al.Cardiovascular incidence in 6900 patients with differentiated thyroid cancer:a Swedish nationwide study[J].World J Surg,2020,44(2):436-441.DOI:10.1007/s00268-019-05249-8.
[13] Bel Lassen P,Kyrilli A,Lytrivi M,et al.Graves' disease,multinodular goiter and subclinical hyperthyroidism[J].Ann Endocrinol(Paris),2019,80(4):240-249.DOI:10.1016/j.ando.2018.09.004.
[14] Rajão KMAB,Ribeiro ALP,Passos VMA,et al.Subclinical thyroid dysfunction was not associated with cardiac arrhythmias in a cross-sectional analysis of the ELSA-Brasil study[J].Arq Bras Cardiol,2019,112(6):758-766.DOI:10.5935/abc.20190037.
[15] Larsson SC,Allara E,Mason AM,et al.Thyroid function and dysfunction in relation to 16 cardiovascular diseases [J].Circ Genom Precis Med,2019,12(3):e002468.DOI:10.1161/CIRCGEN.118.002468.
[16] Roberts L,McCahon D,Johnson O,et al.Stability of thyroid function in older adults:the Birmingham elderly thyroid study [J].Br J Gen Pract,2018,68(675):e718-726.DOI:10.3399/bjgp18X698861.
[17] Gold MR.Response by Gold to letter regarding article,"treatment of subclinical atrial fibrillation:does one plus one always equal two?" [J].Circulation,2018,138(1):124.DOI:10.1161/CIRCULATIONAHA.118.034858.
[18] Dischinger U,Fassnacht M.Thyroid gland and the heart:pathophysiological background,diagnostic and therapeutic consequences [J].Internist(Berl),2018,59(7):668-673.DOI:10.1007/s00108-018-0441-2.
[19] Biondi B,Palmieri EA,Fazio S,et al.Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients[J].J Clin Endocrinol Metab,2000,85(12):4701-4705.DOI:10.1210/jcem.85.12.7085.
[20] Salem JE,Shoemaker MB,Bastarache L,et al.Association of thyroid function genetic predictors with atrial fibrillation:a phenome-wide association study and inverse-variance weighted average meta-analysis [J].JAMA Cardiol,2019,4(2):136-143.DOI:10.1001/jamacardio.2018.4615.

相似文献/References:

[1]刘洪宇,李征,郭莹,等.肢端肥大症患者治疗前后心脏结构和功能的变化[J].国际内分泌代谢杂志,2021,41(04):318.[doi:10.3760/cma.j.cn121383-20200723-07060]
　Liu Hongyu,Li Zheng,Guo Ying,et al.Changes of cardiac structure and function in patients with acromegaly before and after treatment[J].International Journal of Endocrinology and Metabolism,2021,41(06):318.[doi:10.3760/cma.j.cn121383-20200723-07060]

备注/Memo

备注/Memo:
基金项目:天津市胸科医院支持课题(2018XKZ31)
通信作者:苏文凌, Email:13820515519@163.com
更新日期/Last Update: 2021-12-10